R
Arcus Biosciences, Inc.
RCUS · NYSE · Healthcare · 3.7B
Closing price
$24.41
+2.43% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
4.2×
Enterprise value / EBITDAEV/EBITDA
-7.5×
Free cash flow yieldFCF yield
-18.5%
Return on equityROE
-55.9%
Operating margin
-156.3%
Net debt / EBITDAbalance-sheet strength
0.3×
Interest coverage
-48.3×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.